Singh Govind MD is categorized under Business Services (Unclassified) in Colfax, WA and active since 2013.
Singh Govind MD was established in 2013, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.
If you are seeking more information, feel free to contact Govind Singh at the company’s single location by writing to 1210 West Fairview St, Colfax, Washington WA 99111 or by phoning (509) 397-4717. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Singh Govind MD |
| Contact Person: | Govind Singh |
| Address: | 1210 West Fairview St, Colfax, Washington 99111 |
| Phone Number: | (509) 397-4717 |
| Website Address: | whitmanmedical.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Services (Unclassified) |
| SIC Code: | 7389 |
| NAICS Code: | 561499 |
| Share This Business: |
Singh Govind MD was started in 2013 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Govind Singh for inquiries that concern Singh Govind MD by calling the company number (509) 397-4717, as your correspondence is most welcome. Additionally, the physical location of the single location of Singh Govind MD can be found at the coordinates 46.86914,-117.3748 as well as the street address 1210 West Fairview St in Colfax, Washington 99111.
For its online presence, you may visit Singh Govind MD’s website at whitmanmedical.com and engage with its social media outlets through on Twitter and on Facebook.